Established Practice in Diabetes Management: Subcutaneous injections are well-established in diabetes treatment, especially for drugs like GLP-1 receptor agonists
While much of the current research points towards potential anti-inflammatory benefits (e.g., in psoriasis), it's theoretically plausible that GLP-1 receptor activation could subtly alter the skin's immune response to environmental stressors, including UV radiation
Heartburn and acid reflux These can be worsened by GLP-1 medications because slowed gastric emptying means stomach contents, including acid, remain in the stomach longer
Neither efpeglenatide nor ITCA 650 have received marketing authorisation by the FDA or EMA
With DISONCAREs cooling solutions , you can safely store and carry your GLP-1 medication wherever life takes you making it easier to stay on track, every step of the way.
Weight loss during GLP-1 treatment may be associated with changes in how some people experience sweating, though this varies between individuals and scientific evidence for direct effects on thermoregulation is limited
